Conmed (CNMD) Tops Q4 EPS by 8c, Offers Guidance
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $32.54 -0.12%
Revenue Growth %: -0.5%
Financial Fact:
Income before income taxes: 9.99M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: -0.5%
Financial Fact:
Income before income taxes: 9.99M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Conmed (NASDAQ: CNMD) reported Q4 EPS of $0.84, $0.08 better than the analyst estimate of $0.76. Revenue for the quarter came in at $252.8 million versus the consensus estimate of $262.94 million.
GUIDANCE:
Conmed sees FY2021 EPS of $2.85-$3.05, versus the consensus of $3.02. Conmed sees FY2021 revenue of $975-1020 million, versus the consensus of $1020 million.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- C.H. Robinson acquires DeSpir Logistics for $75 million
- Credo Technology pops 3.5% as Evercore initiates with monster $325 price target
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
